Allscripts Included in New NASDAQ Global Select Market

Allscripts (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, announced today that it is included in the new NASDAQ Global Select Market

CHICAGO (July 06, 2006) –

Allscripts (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, announced today that it is included in the new NASDAQ Global Select Market. The NASDAQ listing tier has the highest initial listing standards of any exchange in the world, with measures including market value, liquidity and earnings. The change took effect July 5. Previously, Allscripts had been listed on the NASDAQ National Market.

In conjunction with the creation of the new Global Select Market tier, NASDAQ will rename the NASDAQ National Market to NASDAQ Global Market. The stock exchange also plans to launch indices based on these new tiers early this month. The NASDAQ Capital Market will remain as is.

“Qualifying for NASDAQ’s Global Select Market is a significant achievement for our company,” said Glen Tullman, Chief Executive Officer of Allscripts. “This classification underscores our ongoing commitment to the highest financial and corporate governance standards, and our focus on delivering value to our shareholders and customers.”

Allscripts solutions connect and inform more than 20,000 physicians in over 4,000 ambulatory and acute-care settings across the nation. By automating and streamlining everyday clinical tasks, from ordering prescriptions to billing for services, Allscripts solutions improve the efficiency and quality of care. Connecting physicians to patients and all other stakeholders, Allscripts transforms healthcare, delivering just right, just-in-time information(TM) where it’s needed most – at the point of care.

NASDAQ announced the new three-tier listing classification in February 2006. All three market tiers will maintain rigorous listing and corporate governance standards. For additional information about the NASDAQ Global Select Market, please go to: www.nasdaq.com/GlobalSelect.

About Allscripts

Allscripts is the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare. The Company’s business groups provide unique solutions that inform, connect and transform healthcare. The Clinical Solutions Group’s award-winning software applications include electronic health record, practice management, e-prescribing, document imaging, emergency department and care management solutions. Additionally, Allscripts provides clinical product education and connectivity solutions for physicians and patients through its Physicians Interactive(TM) Group and medication fulfillment services through its Medication Services Group. To learn more, visit Allscripts on the Web at www.allscripts.com.

About NASDAQ

NASDAQ is the largest U.S. electronic stock market. With approximately 3,200 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. It is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media and biotechnology. NASDAQ is the primary market for trading NASDAQ-listed stocks. For more information about NASDAQ, visit www.nasdaq.com or the NASDAQ Newsroom at http://www.nasdaq.com/newsroom/.

This announcement may contain forward-looking statements about Allscripts Healthcare Solutions that involve risks and uncertainties. These statements are developed by combining currently available information with Allscripts beliefs and assumptions. Forward-looking statements do not guarantee future performance. Because Allscripts cannot predict all of the risks and uncertainties that may affect it, or control the ones it does predict, Allscripts’ actual results may be materially different from the results expressed in its forward-looking statements. For a more complete discussion of the risks, uncertainties and assumptions that may affect Allscripts, see the Company’s 2005 Annual Report on Form 10-K, available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov.

CONTACT: Allscripts
Bill Davis, 312-506-1211
bill.davis@allscripts.com

SOURCE: Allscripts

Source: Allscripts